Business Hours
M-F 9am-5pm, Sa-Su Closed
Services
Diabetes Research Tools – Offering ILC cells for in vitro studies, drug research, and toxicity tests, Cell Therapy Development – Advancing autologous and allogeneic stem cell therapies for diabetes, Stem Cell Differentiation – Developing proprietary methods to create pancreatic islet-like cells, Clinical Trial Preparation – Pre-clinical development for cellular therapeutics targeting diabetes.
Specialties
Stem Cell Research – Focused on the differentiation of pluripotent stem cells into pancreatic islet, Diabetes Treatment Innovation – Developing novel therapies to restore insulin production in patients, Cellular Therapeutics – Pre-clinical development of autologous and allogeneic stem cell therapies., Pancreatic Islet Biology – Specializing in creating islet-like clusters that mimic human pancreatic, iPSC Technology – Utilizing induced pluripotent stem cells (iPSCs) for diabetes research and treatme, Drug Discovery Tools – Providing reliable, scalable ILC cells for research and testing., Toxicity Screening – Using ILC cells to screen for toxicity and efficacy in drug development.
Year Established
2012
